EP3616722
PHARMACEUTICAL COMPOSITION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.4.2018EP published:
25.10.2023EP application number:
18791303.3
EPO information:
European Patent Register
Max expiry date:
26.4.2038
Title in English:
PHARMACEUTICAL COMPOSITIONLanguage of the patent:
English
Timeline
Today
27.4.2018EP application
25.10.2023EP Publication
Owner
Name:
Astellas Pharma Inc.Address:
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411, JP
Inventor
Name:
YOSHIDA TakatsuneAddress:
Tokyo 103-8411, JP
Name:
KOJIMA HiroyukiAddress:
Tokyo 103-8411, JP
Name:
UMEMOTO YoshiakiAddress:
Tokyo 103-8411, JP
Name:
NAMIKI SachieAddress:
Tokyo 103-8411, JP
Name:
TAKAGI AkiraAddress:
Tokyo 103-8411, JP
Name:
SHIMADA KenAddress:
Tokyo 103-8411, JP
Priority
Number:
2017090299Date:
28.4.2017Country:
JP
Classification
Categories:
A61K 45/00, A61K 31/4422, A61K 47/32, A61K 9/16, A61K 31/436